308 related articles for article (PubMed ID: 23910300)
1. Bioactive silica-based nanomaterials for doxorubicin delivery: evaluation of structural properties associated with release rate.
Prokopowicz M
Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):3942-50. PubMed ID: 23910300
[TBL] [Abstract][Full Text] [Related]
2. Bioactive silica-based drug delivery systems containing doxorubicin hydrochloride: in vitro studies.
Prokopowicz M; Zegliński J; Gandhi A; Sawicki W; Tofail SA
Colloids Surf B Biointerfaces; 2012 May; 93():249-59. PubMed ID: 22325320
[TBL] [Abstract][Full Text] [Related]
3. Formulation, characterisation and in vitro studies of doxorubicin-loaded silica-polydimethylsiloxane granules.
Prokopowicz M
Eur J Pharm Sci; 2015 Jan; 66():10-9. PubMed ID: 25281914
[TBL] [Abstract][Full Text] [Related]
4. YVO4:Eu3+ functionalized porous silica submicrospheres as delivery carriers of doxorubicin.
Cheng Z; Ma P; Hou Z; Wang W; Dai Y; Zhai X; Lin J
Dalton Trans; 2012 Feb; 41(5):1481-9. PubMed ID: 22124278
[TBL] [Abstract][Full Text] [Related]
5. Correlation between physicochemical properties of doxorubicin-loaded silica/polydimethylsiloxane xerogel and in vitro release of drug.
Prokopowicz M
Acta Biomater; 2009 Jan; 5(1):193-207. PubMed ID: 18755642
[TBL] [Abstract][Full Text] [Related]
6. Formulation and In Vitro Characterization of Bioactive Mesoporous Silica with Doxorubicin and Metronidazole Intended for Bone Treatment and Regeneration.
Czarnobaj K; Prokopowicz M; Sawicki W
AAPS PharmSciTech; 2017 Nov; 18(8):3163-3171. PubMed ID: 28534298
[TBL] [Abstract][Full Text] [Related]
7. Investigation of emulsified, acid and acid-alkali catalyzed mesoporous bioactive glass microspheres for bone regeneration and drug delivery.
Miao G; Chen X; Dong H; Fang L; Mao C; Li Y; Li Z; Hu Q
Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):4236-43. PubMed ID: 23910338
[TBL] [Abstract][Full Text] [Related]
8. Sol-gel processing of anti-inflammatory entrapment in silica, release kinetics, and bioactivity.
Catauro M; Melisi D; Curcio A; Rimoli MG
J Biomed Mater Res A; 2008 Dec; 87(4):843-9. PubMed ID: 18200553
[TBL] [Abstract][Full Text] [Related]
9. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
10. Sol-gel processing of drug delivery materials and release kinetics.
De Gaetano F; Ambrosio L; Raucci MG; Marotta A; Catauro M
J Mater Sci Mater Med; 2005 Mar; 16(3):261-5. PubMed ID: 15744618
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.
Li C; Yang D; Ma P; Chen Y; Wu Y; Hou Z; Dai Y; Zhao J; Sui C; Lin J
Small; 2013 Dec; 9(24):4150-9. PubMed ID: 23843254
[TBL] [Abstract][Full Text] [Related]
12. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
Yang P; Huang S; Kong D; Lin J; Fu H
Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro characterisation of bioactive mesoporous silica microparticles for drug delivery applications.
Prokopowicz M; Czarnobaj K; Szewczyk A; Sawicki W
Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():7-18. PubMed ID: 26706501
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of sol-gel mesoporous silica materials providing a slow release of doxorubicin.
Prokopowicz M; Przyjazny A
J Microencapsul; 2007 Nov; 24(7):682-701. PubMed ID: 17763062
[TBL] [Abstract][Full Text] [Related]
15. pH-sensitive poly(glutamic acid) grafted mesoporous silica nanoparticles for drug delivery.
Zheng J; Tian X; Sun Y; Lu D; Yang W
Int J Pharm; 2013 Jun; 450(1-2):296-303. PubMed ID: 23598077
[TBL] [Abstract][Full Text] [Related]
16. Zirconium phosphate nanoplatelets: a biocompatible nanomaterial for drug delivery to cancer.
Saxena V; Diaz A; Clearfield A; Batteas JD; Hussain MD
Nanoscale; 2013 Mar; 5(6):2328-36. PubMed ID: 23392208
[TBL] [Abstract][Full Text] [Related]
17. Molybdenum effect on the structure of SiO₂-CaO-P₂O₅ bioactive xerogels and on their interface processes with simulated biofluids.
Ponta O; Ciceo-Lucacel R; Vulpoi A; Radu T; Simon S
J Biomed Mater Res A; 2014 Sep; 102(9):3177-85. PubMed ID: 24142573
[TBL] [Abstract][Full Text] [Related]
18. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
[TBL] [Abstract][Full Text] [Related]
19. Surface-Activated Fibre-Like SBA-15 as Drug Carriers for Bone Diseases.
Prokopowicz M; Żeglinski J; Szewczyk A; Skwira A; Walker G
AAPS PharmSciTech; 2018 Dec; 20(1):17. PubMed ID: 30574669
[TBL] [Abstract][Full Text] [Related]
20. Hierarchical self-assembly of heparin-PEG end-capped porous silica as a redox sensitive nanocarrier for doxorubicin delivery.
Nguyen Thi TT; Tran TV; Tran NQ; Nguyen CK; Nguyen DH
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 2):947-954. PubMed ID: 27772725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
